Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Imke Metz

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
Frontiers in Immunology|April 5, 2018
Detailed Characterization of T Cell Receptor Repertoires in Multiple Sclerosis Brain LesionsRaquel Planas, Imke Metz, Roland Martin, et al.
Therapeutic Advances in Neurological Disorders|April 7, 2018
Defining distinct features of anti-MOG antibody associated central nervous system demyelinationMartin S Weber, Tobias Derfuss, Imke Metz, et al.
Acta Neuropathologica Communications|August 10, 2016
Disseminated necrotizing leukoencephalopathy eight months after alemtuzumab treatment for multiple sclerosisImke Metz, Peter Rieckmann, Boris-Alexander Kallmann, et al.
Acta Neuropathologica|January 22, 2015
High CCR5 expression in natalizumab-associated progressive multifocal leukoencephalopathy immune reconstitution inflammatory syndrome supports treatment with the CCR5 inhibitor maravirocLidia Stork, Wolfgang Brück, Amit Bar-Or, et al.
Neuropathology and Applied Neurobiology|February 3, 2015
Natalizumab analogon therapy is effective in a B cell-dependent multiple sclerosis modelDarius Häusler, Stefan Nessler, Niels Kruse, et al.
Acta Neuropathologica|April 1, 2025
Impaired remyelination in late-onset multiple sclerosisLidia Stork, Schirin Stephan, Adriane Kutllovci, et al.
Therapeutic Advances in Neurological Disorders|March 20, 2018
Rescue therapy with alemtuzumab in B cell/antibody-mediated multiple sclerosisKatja Akgün, Imke Metz, Hagen H Kitzler, et al.
Journal of the Neurological Sciences|November 15, 2012
Atypical chronic lymphocytic inflammation with pontocerebellar perivascular enhancement responsive to steroids (CLIPPERS), primary angiitis of the CNS mimicking CLIPPERS or overlap syndrome? A case reportMathias Buttmann, Imke Metz, Isabel Brecht, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 11, 2026
Brain Immune Cell Composition in Multiple Sclerosis and Progressive Multifocal Leukoencephalopathy After Natalizumab: An Immunohistochemical Cohort StudyBenita-Sophie Raabe, Lidia Stork, Adriane Kutllovci, et al.
Journal of Neurology|November 14, 2022
Neurofilament light chains in serum as biomarkers of axonal damage in early MS lesions: a histological-serological correlative studyAnne-Sophie Dietmann, Niels Kruse, Lidia Stork, et al.
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
Frontiers in Immunology|April 5, 2018
Detailed Characterization of T Cell Receptor Repertoires in Multiple Sclerosis Brain LesionsRaquel Planas, Imke Metz, Roland Martin, et al.
Therapeutic Advances in Neurological Disorders|April 7, 2018
Defining distinct features of anti-MOG antibody associated central nervous system demyelinationMartin S Weber, Tobias Derfuss, Imke Metz, et al.
Acta Neuropathologica Communications|August 10, 2016
Disseminated necrotizing leukoencephalopathy eight months after alemtuzumab treatment for multiple sclerosisImke Metz, Peter Rieckmann, Boris-Alexander Kallmann, et al.
Acta Neuropathologica|January 22, 2015
High CCR5 expression in natalizumab-associated progressive multifocal leukoencephalopathy immune reconstitution inflammatory syndrome supports treatment with the CCR5 inhibitor maravirocLidia Stork, Wolfgang Brück, Amit Bar-Or, et al.
Neuropathology and Applied Neurobiology|February 3, 2015
Natalizumab analogon therapy is effective in a B cell-dependent multiple sclerosis modelDarius Häusler, Stefan Nessler, Niels Kruse, et al.
Acta Neuropathologica|April 1, 2025
Impaired remyelination in late-onset multiple sclerosisLidia Stork, Schirin Stephan, Adriane Kutllovci, et al.
Therapeutic Advances in Neurological Disorders|March 20, 2018
Rescue therapy with alemtuzumab in B cell/antibody-mediated multiple sclerosisKatja Akgün, Imke Metz, Hagen H Kitzler, et al.
Journal of the Neurological Sciences|November 15, 2012
Atypical chronic lymphocytic inflammation with pontocerebellar perivascular enhancement responsive to steroids (CLIPPERS), primary angiitis of the CNS mimicking CLIPPERS or overlap syndrome? A case reportMathias Buttmann, Imke Metz, Isabel Brecht, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 11, 2026
Brain Immune Cell Composition in Multiple Sclerosis and Progressive Multifocal Leukoencephalopathy After Natalizumab: An Immunohistochemical Cohort StudyBenita-Sophie Raabe, Lidia Stork, Adriane Kutllovci, et al.
Journal of Neurology|November 14, 2022
Neurofilament light chains in serum as biomarkers of axonal damage in early MS lesions: a histological-serological correlative studyAnne-Sophie Dietmann, Niels Kruse, Lidia Stork, et al.
Pageof 8